More About The Derek Tan Lab Minus iconIcon indicating subtraction, or that the element can be closed. Plus IconIcon indicating addition, or that the element can be opened. Arrow (down) icon.An arrow icon, usually indicating that the containing element can be opened and closed.

Group Meeting Papers 2005

Here is a list of research papers that were presented for discussion in our 2005 weekly group meetings. Papers are selected by group members as a means to broaden our knowledge in chemistry and chemical biology.


12 Dec 2005, presented by Sirkka Moilanen
Cell-specific targeting of nanoparticles by multivalent attachment of small molecules.
Weissleder, R.*; Kelly, K.; Sun, E. Y.; Shtatland, T.; Josephson, L. Nat. Biotechnol. 2005, 23, 1418-1423.
[ Abstract ]

5 Dec 2005, presented by Xuequan Lu
From nonpeptide toward noncarbon protease inhibitors: Metallacarboranes as specific and potent inhibitors of HIV protease.
Cígler, P.; Kožíšek, M.; Řezáčová, P.; Brynda, J.; Otwinowski, Z.; Pokorná, J.; Plešek, J.; Grüner, B.; Dolečková-Marešová, L.; Máša, M.; Sedláček, J.; Bodem, J.; Kräusslich, H.-G.; Král, V.; Konvalinka, J.* Proc. Natl. Acad. Sci. USA 2005, 102, 15394-15399.
[ Abstract ]

28 Nov 2005, presented by Hayato Iwadare
Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis.
Camps, M.; Rückle, T.; Ji, H.; Ardissone, V.; Ritelen, F.; Shaw, J.; Ferrandi, C.; Chabert, C.; Gillieron, C.; Françon, B.; Martin, T.; Gretener, D.; Perrin, D.; Leroy, D.; Vitte, P.-A.; Hirsch, E.; Wymann, M. P.; Cirillo, R.; Schwarz, M. K.; Rommel, C.* Nat. Med. 2005, 11, 936-943.
[ Abstract ]

21 Nov 2005, presented by Justin Potuzak
Small-molecule inhibition of TNF-α.
He, M. M.; Stroustrup Smith, A.; Oslob, J. D.; Flanagan, W. M.; Braisted, A. C.; Whitty, A.; Cancilla, M. T.; Wang, J.; Lugovskoy, A. A.; Yoburn, J. C.; Fung, A. D.; Farrington, G.; Eldredge, J. K.; Day, E. S.; Cruz, L. A.; Cachero, T. G.; Miller, S. K.; Friedman, J. E.; Choong, I. C.; Cunningham, B. C.* Science 2005, 310, 1022-1025.
[ Abstract ]

14 Nov 2005, presented by Justin Cisar
A proteome-wide CDK/CRK-specific kinase inhibitor promotes tumor cell death in the absence of cell cycle progression.
Caligiuri, M.; Becker, F.; Murthi, K.; Kaplan, F.; Dedier, S.; Kaufmann, C.; Machl, A.; Zybarth, G.; Richard, J.; Bockovich, N.; Kluge, A.; Kley, N.* Chem. Biol. 2005, 12, 1103-1115.
[ Abstract ]

24 Oct 2005, presented by Christine DiBlasi
The melanocyte differentiation program predisposes to metastasis after neoplastic transformation.
Gupta, P. B.; Kuperwasser, C.; Brunet, J.-P.; Ramaswamy, S.; Kuo, W.-L.; Gray, J. W.; Naber, S. P.; Weinberg, R. A.* Nat. Genet. 2005, 37, 1047-1054.
[ Abstract ]

17 Oct 2005, presented by Shiying Shang
EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans.
Koprivica, V.; Cho, K.-S.; Park, J. B.; Yiu, G.; Atwal, J.; Gore, B.; Kim, J. A.; Lin, E.; Tessier-Lavigne, M.; Chen, D. F.; He, Z.* Science 2005, 310, 106-110.
[ Abstract ]

10 Oct 2005, presented by Sirkka Moilanen
Target discovery in small-molecule cell-based screens by in situ proteome reactivity profiling.
Evans, M. J.; Saghatelian, A.; Sorensen, E. J.; Cravatt, B. F.* Nat. Biotechnol. 2005, 23, 1303-1307.
[ Abstract ]

03 Oct 2005, presented by Hayato Iwadare
Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors.
Idris, A. I.; van’t Hof, R. J.; Greig, I. R.; Ridge, S. A.; Baker, D.; Ross, R. A.; Ralston, S. H.* Nat. Med. 2005, 11, 774-779.
[ Abstract ]

26 Sep 2005, presented by Justin Potuzak
Discovery of a new peptide natural product by Streptomyces coelicolor genome mining.
Lautru, S.; Deeth, R. J.; Bailey, L. M.; Challis, G. L.* Nat. Chem. Biol. 2005, 1, 265-269.
[ Abstract ]

19 Sep 2005, presented by Christine DiBlasi
Induction of interleukin-8 preserves the angiogenic response in HIF-1α-deficient colon cancer cells.
Mizukami, Y.; Jo, W.-S.; Duerr, E.-M.; Gala, M.; Li, J.; Zhang, X.; Zimmer, M. A.; Iliopoulos, O.; Zukerberg, L. R.; Kohgo, Y.; Lynch, M. P.; Rueda, B. R.; Chung D. C.* Nat. Med. 2005, 11, 992-997.
[ Abstract ]

06 Sep 2005, presented by Justin Cisar
Enhancing the anticancer properties of cardiac glycosides by neoglycorandomization.
Langehan, J. M.; Peters, N. R.; Guzei, I. A.; Hoffmann, F. M.; Thorson, J. S.* Proc. Natl. Acad. Sci. USA 2005, 102, 12305-12310.
[ Abstract ]

29 Aug 2005, presented by Shiying Shang
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury.
Degterev, A.; Huang, Z.; Boyce, M.; Li, Y.; Jagtap, P.; Mizushima, N.; Cuny, G. D.; Mitchison, T. J.; Moskowitz, M. A.; Yuan, J.* Nat. Chem. Biol. 2005, 1, 112-119
[ Abstract ]

22 Aug 2005, presented by Sirkka Moilanen
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system.
Sengupta, S.; Eavarone, D.; Capila, I.; Zhao, G.; Watson, N.; Kiziltepe, T.; Sasisekharan, R.* Nature 2005, 436, 568-572.
[ Abstract ]

15 Aug 2005, presented by Hayato Iwadare
Structure activity relationships and quantitative structure activity relationships for the flavonoid-mediated inhibition of breast cancer resistance protein.
Zhang, S.; Yang, X.; Coburn, R. A.; Morris, M. E.* Biochem. Pharmacol. 2005, 70, 627-639.
[ Abstract ]

8 Aug 2005, presented by Daniel Macks
Stimulation of mammalian translation initiation factor eIF4A activity by a small molecule inhibitor of eukaryotic translation.
Bordeleau, M.-E.; Matthews, J.; Wojnar, J. M.; Lindqvist, L.; Novac, O.; Jankowsky, E.; Sonenberg, N.; Northcote, P.; Teesdale-Spittle, P.; Pelletier, J.* Proc. Natl. Acad. Sci. USA 2005, 102, 10460-10465.
[ Abstract ]

1 Aug 2005, presented by Justin Potuzak
Efficient synthetic inhibitors of anthrax lethal factor.
Forino, M.; Johnson, S.; Wong, T. Y.; Rozanov, D. V.; Savinov, A. Y.; Li, W.; Fattorusso, R.; Becattini, B.; Orry, A. J.; Jung, D.; Abagyan, R. A.; Smith, J. W.; Alibek, K.; Liddington, R. C.; Strongin, A. Y.; Pellecchia, M.* Proc. Natl. Acad. Sci. USA 2005, 102, 9499-9504.
[ Abstract ]

11 Jul 2005, presented by Justin Cisar
Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages.
Rengarajan, J.; Bloom, B. R.; Rubin, E. J.* Proc. Natl. Acad. Sci. USA 2005, 102, 8327-8332.
[ Abstract ]

5 July 2005, presented by Christine DiBlasi
Stat3 is required for ALK-mediated lympomagenesis and provides a possible therapeutic target.
Chiarle, R.; Simmons, W. J.; Cai, H.; Dhall, G.; Zamo, A.; Raz, R.; Karras, J. G.; Levy, D. E.; Inghirami, G.* Nat. Med. 2005, 11, 623-629.
[ Abstract ]

27 Jun 2005, presented by Shiying Shang
An inhibitor of Bcl-2 family proteins induces regression of solid tumours.
Oltersdorf, T.; Elmore, S. W.; Shoemaker, A. R.; Armstrong, R. C.; Augeri, D. J.; Belli, B. A.; Bruncko, M.; Deckwerth, T. L.; Dinges, J.; Hajduk, P. J.; Joseph, M. K.; Kitada, S.; Korsmeyer, S. J.; Kunzer, A. R.; Letai, A.; Li, C.; Mitten, M. J.; Nettesheim, D. G.; Ng, S.; Nimmer, P. M.; O’Connor, J. M.; Oleksijew, A.; Petros, A. M.; Reed, J. C.; Shen, W.; Tahir, S. K.; Thompson, C. B.; Tomaselli, K. J.; Wang, B.; Wendt, M. D.; Zhang, H.; Fesik, S. W.*; Rosenberg, S. H.* Nature 2005, 435, 677-681
[ Abstract ]

30 May 2005, presented by Sirkka Moilanen
Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors.
Song, W.; Zhu, P.; Lee, S.-K.; Chowdhury, D.; Kussman, S.; Dykxhoorn, D. M.; Feng, Y.; Palliser, D.; Weiner, D. B.; Shankar, P.; Marasco, W. A.; Lieberman, J.* Nat. Biotechnol. 2005, 23, 709-717.
[ Abstract ]

16 May 2005, presented by Hayato Iwadare
Structual basis for antagonism and resistance of bicalutamide in prostate cancer.
Bohl, C. E.; Gao, W.; Miller, D. D.; Bell, C. E.*; Dalton, J. T.* Proc. Natl. Acad. Sci. USA 2005, 102, 6201-6206.
[ Abstract ]

9 May 2005, presented by Jae-Sang Ryu
Allosteric inhibition of protein tyrosine phosphatase 1B.
Weismann, C.; Barr, K. J.; Kung, J.; Zhu, J.; Erlanson, D. A.; Shen, W.; Fahr, B. J.; Zhong, M.; Taylor, L.; Randal, M.; McDowell, R. S.; Hansen, S. K.* Nat. Struct. Mol. Biol. 2004, 11, 730-737.
[ Abstract ]

2 May 2005, presented by Justin Potuzak
Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice.
Shan, D.; Chen, L.; Njardarson, J. T.; Gaul, C.; Ma, X.; Danishefsky, S. J.; Huang, X.-Y.* Proc. Natl. Acad. Sci. USA 2005, 102, 3772-3776.
[ Abstract ]

25 Apr 2005, presented by Christine DiBlasi
A small molecule-kinase interaction map for clinical kinase inhibitors.
Fabian, M. A.; Biggs, W. H.; Treiber, D. K.; Atteridge, C. E.; Azimioara, M. D.; Benedetti, M. G.; Carter, T. A.; Ciceri, P.; Edeen, P. T.; Floyd, M.; Ford, J. M.; Galvin, M.; Gerlach, J. L.; Grotzfeld, R. M.; Herrgard, S.; Insko, D. E.; Insko, M. A.; Lai, A. G; Lélias, J.-M.; Mehta, S. A.; Milanov, Z. V.; Velasco, A. M.; Wodicka, L. M.; Patel, H. K.; Zarrinkar, P. P.*; Lockhart, D. J.* Nat. Biotechnol. 2005, 23, 329-336.
[ Abstract ]

4 Apr 2005, presented by Justin Potuzak
Combating drug-resistant bacteria: Small molecule mimics of plasmid incompatibility as antiplasmid compounds.
DeNap, J. C. B.; Thomas, J. R.; Musk, D. J.; Hergenrother, P. J.* J. Am. Chem. Soc. 2005, 126, 15402-15404.
[ Abstract ]

14 Mar 2005, presented by Justin Cisar
A non-ATP-competative inhibitor of BCR-ABL overrides imatinib resistance.
Gumireddy, K.; Baker, S. J.; Cosenza, S. C.; John, P.; Kang, A. D.; Robell, K. A.; Reddy, M. V. R.; Reddy, E. P.* Proc. Natl. Acad. Sci. USA 2005, 102, 1992-1997.
[ Abstract ]

21 Feb 2005, presented by Sirkka Moilanen
Label-free detection of small-molecule-protein interactions by using nanowire nanosensors.
Wang, W. U.; Chen, C.; Lin, K.-h.; Fang, Y.; Lieber, C. M.* Proc. Natl. Acad. Sci. USA 2005, 102, 3208-3212.
[ Abstract ]

14 Feb 2005, presented by Jae-Sang Ryu
A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design.
Card, G. L.; Blasdel, L.; England, B. P.; Zhang, C.; Suzuki, Y.; Gillette, S.; Fong, D.; Ibrahim, P. N.; Artis, D. R.; Bollag, G.; Milburn, M. V.; Kim, S.-H.; Schlessinger, J.; Zhang, K. Y. J.* Nat. Biotechnol. 2005, 23, 201-207.
[ Abstract ]

3 Jan 2005, presented by Sirkka Moilanen
Tumor imaging by means of proteolytic activation of cell-penetrating peptides.
Jiang, T.; Olson, E. S.; Nguyen, Q. T.; Roy, M.; Jennings, P. A.; Tsien, R. Y.* Proc. Natl. Acad. Sci. USA 2004, 101, 17867-17872.
[ Abstract ]